Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features
Authors:
- Marcello Andrea TipaldiMTMarcello Andrea Tipaldi
- Edoardo RonconiEdoardo Ronconi
- Elena LucertiniELElena Lucertini
- Miltiadis KrokidisMKMiltiadis Krokidis
- Marta ZerunianMZMarta Zerunian
- Tiziano PolidoriTPTiziano Polidori
- Paola BeginiPBPaola Begini
- Massimo MarignaniMMMassimo Marignani
- Federica MazzucaFMFederica Mazzuca
- Damiano CarusoDamiano Caruso
- Michele RossiMRMichele Rossi
- Andrea LaghiALAndrea Laghi
Open Access
- 26 May 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 956
Abstract
(1) Introduction and Aim: The aim of this study is to investigate the prognostic value, in terms of response and survival, of CT-based radiomics features for patients with HCC undergoing drug-eluting beads transarterial chemoembolization (DEB-TACE). (2) Materials and Methods: Pre-treatment CT examinations of 50 patients with HCC, treated with DEB-TACE were manually segmented to obtain the tumor volumetric region of interest, extracting radiomics features with TexRAD. Response to therapy evaluation was performed basing on post-procedural CT examination compared to pre-procedural CT, using modified RECIST criteria for HCC. The prognostic value of texture analysis was evaluated, investigating the correlation between radiomics features, response to therapy and overall survival. Three models based on texture and clinical variables and a combination of them were finally built; (3) Results: Entropy, skewness, MPP and kurtosis showed a significant correlation with complete response (CR) to TACE (all p < 0.001). A predictive model to identify patients with a high and low probability of CR was evaluated with an ROC curve, with an AUC of 0.733 (p < 0.001). The three models built for survival prediction yielded an HR of 2.19 (95% CI: 2.03–2.35) using texture features, of 1.7 (95% CI: 1.54–1.9) using clinical data and of 4.61 (95% CI: 4.24–5.01) combining both radiomics and clinical data (all p < 0.0001). (4) Conclusion: Texture analysis based on pre-treatment CT examination is associated with response to therapy and survival in patients with HCC undergoing DEB-TACE, especially if combined with clinical data.Keywords
This publication has 30 references indexed in Scilit:
- Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenibOncotarget, 2016
- Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysisDigestive and Liver Disease, 2016
- Role of quantitative computed tomography texture analysis in the differentiation of primary lung cancer and granulomatous nodules2016
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective studyBMC Surgery, 2014
- The laparoscopic hiatoplasty with antireflux surgery is a safe and effective procedure to repair giant hiatal herniaBMC Surgery, 2014
- Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial ChemoembolizationPLOS ONE, 2013
- Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survivalEuropean Radiology, 2011
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004